TRCT
KMTS

Tower Research Capital (TRC)’s Kestra Medical Technologies KMTS Stock Holding History

Tower Research Capital (TRC)’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.2K Sell
1,895
-375
-17% -$7.85K ﹤0.01% 2766
2026
Q1 		$45.2K Buy
2,270
+1,534
+208% +$36.2K ﹤0.01% 2827
2025
Q4 		$19.5K Buy
736
+38
+5% +$979 ﹤0.01% 3111
2025
Q3 		$16.6K Buy
698
+596
+584% +$10.7K ﹤0.01% 3469
2025
Q2 		$1.69K Buy
+102
New +$2.23K ﹤0.01% 4761

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Tower Research Capital (TRC)'s KMTS Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Kestra Medical Technologies (KMTS) stake by 17% in Q2 2026, selling an estimated $7.85K and leaving 1,895 shares worth $48.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2766.

Tower Research Capital (TRC) first reported a position in KMTS in Q2 2025 and has held it in 5 quarters since. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Tower Research Capital (TRC) held 1,895 shares of Kestra Medical Technologies worth $48.2K as of Q2 2026.
  • Tower Research Capital (TRC) sold 375 Kestra Medical Technologies shares in Q2 2026, an estimated $7.85K.
  • Kestra Medical Technologies made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2766 holding.
  • Tower Research Capital (TRC) first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 5 quarters since.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.